CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease.

While no body weight difference between groups was detected on normal diet, a highly significant decrease in weight gain on the HFD was observed in mice implanted with NRIP1 disrupted adipocytes (Fig. 7e ).

also in 132,142 other papers